Optimizing Excipient Properties to Prevent Aggregation in Biopharmaceutical Formulations.

ABSTRACT: Excipients are included within protein biotherapeutic solution formulations to improve colloidal and conformational stability but are generally not designed for the specific purpose of preventing aggregation and improving cryoprotection in solution. In this work, we have explored the relationship between the structure and antiaggregation activity of excipients by utilizing coarse-grained molecular dynamics modeling of protein-excipient interaction. We have studied human serum albumin as a model protein, and we report the interaction of 41 excipients (polysorbates, fatty alcohol ethoxylates, fatty acid ethoxylates, phospholipids, glucosides, amino acids, and others) in terms of the reduction of solvent accessible surface area of aggregation-prone regions, proposed as a mechanism of aggregat

SUBMITTER: King TE 

PROVIDER: S-EPMC10777730 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature